Thought Technology

Montreal, QuebecFounded 1975101–250 employeesthoughttechnology.comLinkedIn

Neurofeedback

Thought Technology is a Montreal-based manufacturer of biofeedback, neurofeedback and psychophysiological monitoring instruments, founded in 1975. Its systems measure and provide real-time feedback on physiological signals for clinical care, rehabilitation, stress management, sports performance and research.

Visit thoughttechnology.com ↗

Founded: 1975
Employees: 101–250

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Thought Technology’s most clearly documented product milestone in 2025 was the April 22 launch of an upgraded eVu-Senz Android app. The update introduced enhanced biofeedback features, improved signal processing, a redesigned interface, and streamlined reporting to support self-regulation. On May 6, 2025, the company highlighted its continued support for the Association for Applied Psychophysiology and Biofeedback (AAPB) conference, including an exhibitor demonstration. Earlier, on January 3, 2024, it announced a co-marketing agreement with Better Physiology. On February 5, 2026, Thought Technology publicized a planned conference showcase of its ProComp and MyOnyx systems. These announcements indicate ongoing activity across software, clinician engagement, and the promotion of established instrumentation. No awards or leadership changes are identified in the available company information, and the conference coverage does not establish the results of the showcase. The company’s recent public milestones are therefore concentrated on product communication and professional-community participation rather than disclosed financing or organizational changes.

Market position

Thought Technology operates in the specialist segment of medical devices and digital health, focused on biofeedback, neurofeedback, and psychophysiological measurement. Its products span hardware, software, and mobile applications: MyOnyx supports surface electromyography (sEMG) biofeedback and electrostimulation, while eVu-TPS sensors and the eVu-Senz app support physiological monitoring and feedback. This combination serves clinical assessment and rehabilitation as well as stress-management, sports, ergonomics, education, and research applications. The company’s differentiation is its emphasis on measuring multiple physiological signals and translating them into real-time feedback, alongside a product range that includes both portable systems and broader monitoring instruments. It also cites ISO 13485 and CE certifications and clinician education activity as elements of its medical-device and professional focus. Its stated categories place it alongside medical-device, healthcare, biotechnology, and software businesses, but its specific biofeedback focus distinguishes its offering from general-purpose digital health platforms.

Growth & opportunities

Founded in 1975, Thought Technology has a long operating history in biofeedback and physiological monitoring, with products serving clinical and non-clinical applications. Recent milestones suggest continued product maintenance and extension rather than a clearly documented shift in business scale. The April 22, 2025 eVu-Senz app upgrade is a notable software inflection point: it brought improvements to signal processing, reporting, and user experience around the company’s biofeedback offering. Its January 2024 co-marketing agreement with Better Physiology also indicates an effort to broaden product visibility through collaboration. In February 2026, the company promoted a showcase of ProComp and MyOnyx systems, continuing its emphasis on established instrumentation and professional audiences. The product portfolio includes MyOnyx, eVu-Senz, the Biofeedback Starter System, Synergy Solution System, and eVu TPS Package. The recorded employee range is 101–250, but it does not establish a growth trend. Overall, the evidence points to incremental product and market-engagement activity, while the company’s financial and workforce trajectory remains unclear.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Thought Technology distinct

reccy insights

What makes Thought Technology distinct

01More than 50 years of experience developing biofeedback and physiological monitoring instruments.
02Combines physiological signal monitoring and analysis with real-time visual or auditory feedback to support self-regulation and conditioning.
03Serves therapeutic treatment and clinical assessment as well as sports, ergonomics, education, and research.
04Maintains ISO 13485 medical-device quality certification and CE certification.
05Supports clinician education through workshops and participation as a corporate founding member of the Biofeedback Federation of Europe.

Technology & products5

Technology & products

MyOnyx Rehab Solution
A handheld device with two surface electromyography (sEMG) sensors that measures and displays muscle activity in real time for rehabilitation purposes.
eVu-Senz App
A mobile application that provides biofeedback monitoring and training.
Biofeedback Starter System
A system that provides basic biofeedback instrumentation for physiological monitoring and training.
Synergy Solution System - T4511
A biofeedback system designed for comprehensive physiological monitoring and feedback.
eVu TPS Package - T4500
A package designed for biofeedback training and physiological monitoring.

Show all 5 products

+ 2 more: Synergy Solution System - T4511, eVu TPS Package - T4500

Recent updates2

Launches, partnerships and team changes from press coverage

Apr 22, 2025Product launch
Thought Technology launched an upgraded Android version of its eVu-Senz App with enhanced biofeedback features, improved signal processing, a redesigned interface, and streamlined report generation.
prnewswire.com
Jan 3, 2024Partnership
Thought Technology announced a co-marketing agreement with Better Physiology.
prweb.com

Similar companies

Show all 6 companies

About Thought Technology

Products: MyOnyx Rehab Solution, eVu-Senz App, Biofeedback Starter System, Synergy Solution System - T4511, eVu TPS Package - T4500
Leadership: Hal K. Myers, Co-Founder, CEO & Chief Innovation OfficerLawrence Klein, Co-Founder & Vice President
Focus areas: Biofeedback, neurofeedback, medical devices, physiological monitoring, rehabilitation, digital health, stress management, sports performance
Headquarters: Montreal, Quebec
Founded: 1975
Employees: 101–250
Patents granted: 1 (Crunchbase)
Trademarks: 1